Literature DB >> 1333129

Sequence characterization and expression of the matrix protein gene of human parainfluenza virus type 1.

U F Power1, K W Ryan, A Portner.   

Abstract

The nucleotide sequence of the M gene of human parainfluenza virus type 1 (hPIV1) was determined from genomic RNA and cDNA copies of the entire gene. The M gene contained 1173 nucleotides. It had one large open reading frame capable of encoding a protein of 348 amino acids (M(r) = 38,404). The predicted amino acid sequence of the hPIV1 M protein is highly basic (+20 at neutral pH). A pGEM-1 expression vector containing the M gene was used for cell-free transcription and translation. The resultant protein was confirmed to be M by electrophoretic mobility and immunoprecipitation. Among other paramyxoviridae the hPIV1 M amino acid sequence was most closely related to the Sendai virus M sequence (87% identity). The pattern of M gene relatedness observed from the alignment of 16 paramyxoviridae M protein amino acid sequences was not predicted by the viruses' taxonomic classification.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333129     DOI: 10.1016/0042-6822(92)90270-y

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein.

Authors:  E C Coronel; T Takimoto; K G Murti; N Varich; A Portner
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Role of matrix and fusion proteins in budding of Sendai virus.

Authors:  T Takimoto; K G Murti; T Bousse; R A Scroggs; A Portner
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 3.  Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.

Authors:  Charles J Russell; Eric A F Simões; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2018-01-11       Impact factor: 2.257

4.  Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut.

Authors:  Rajeev Rudraraju; Sherri Surman; Bart Jones; Robert Sealy; David L Woodland; Julia L Hurwitz
Journal:  Virology       Date:  2011-01-11       Impact factor: 3.616

5.  Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures.

Authors:  E C Coronel; K G Murti; T Takimoto; A Portner
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse genetics.

Authors:  Jason T Newman; Sonja R Surman; Jeffrey M Riggs; Chris T Hansen; Peter L Collins; Brian R Murphy; Mario H Skiadopoulos
Journal:  Virus Genes       Date:  2002       Impact factor: 2.332

7.  The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction.

Authors:  Tatiana Bousse; Tatyana Matrosovich; Allen Portner; Atsushi Kato; Yoshiyuki Nagai; Toru Takimoto
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Identification and genome characterization of genotype B and genotype C bovine parainfluenza type 3 viruses isolated in the United States.

Authors:  John D Neill; Julia F Ridpath; Binu T Valayudhan
Journal:  BMC Vet Res       Date:  2015-05-15       Impact factor: 2.741

9.  First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.

Authors:  Julien Nyombayire; Omu Anzala; Brian Gazzard; Etienne Karita; Philip Bergin; Peter Hayes; Jakub Kopycinski; Gloria Omosa-Manyonyi; Akil Jackson; Jean Bizimana; Bashir Farah; Eddy Sayeed; Christopher L Parks; Makoto Inoue; Takashi Hironaka; Hiroto Hara; Tsugumine Shu; Tetsuro Matano; Len Dally; Burc Barin; Harriet Park; Jill Gilmour; Angela Lombardo; Jean-Louis Excler; Patricia Fast; Dagna S Laufer; Josephine H Cox
Journal:  J Infect Dis       Date:  2016-10-17       Impact factor: 5.226

Review 10.  Respiratory syncytial virus: current progress in vaccine development.

Authors:  Rajeev Rudraraju; Bart G Jones; Robert Sealy; Sherri L Surman; Julia L Hurwitz
Journal:  Viruses       Date:  2013-02-05       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.